Sinclair R, Westlander G, Cassuto J, Hedner T
Department of Anesthesiology, Central Hospital, Mölndal, Sweden.
Acta Anaesthesiol Scand. 1996 May;40(5):589. doi: 10.1111/j.1399-6576.1996.tb04493.x.
To improve postoperative analgesia, local anesthetics have been administered perioperatively as infiltration or as aerosol in the surgical area. A previous study showed good analgesic effects by topical lidocaine in the wound in minor extraabdominal surgery (herniorraphy), while the same treatment in minor lower laparothomies did not improve postoperative analgesia. The present study investigated the effect of topical wound anesthesia using lidocaine aerosol on postoperative pain following major lower abdominal surgery.
Postoperative pain and analgesic requirements were studied in a double-blind randomized trial including 30 hysterectomized patients. Patients were randomized to receive single wound treatment either with lidocaine aerosol 500 mg (100 mg/ml; Xylocain aerosol, ASTRA, Sweden) (n = 15) or placebo aerosol (n = 15). Postoperative pain was evaluated by visual analogue scale (VAS). Requirements of opiate analgesics (buprenorphine) after surgery were monitored.
Lidocaine aerosol induced a significantly (P < 0.001) better analgesia at rest (VAS) and a significant (P < 0.001) reduction in postoperative requirements of buprenorphine during the first 24 hours after surgery compared to placebo aerosol. Differences between the groups in pain scores (VAS) and buprenorphine requirements during the second postoperative day were not significant. Mean pain scores upon mobilization 24 h after surgery were significantly lower in the group receiving lidocaine aerosol (P < 0.05). The plasma lidocaine concentration 4 h after the administration of lidocaine was well below toxic level and plasma lidocaine was detectable 48 h postoperatively. No drug-related side effects were reported.
A single dose of lidocaine aerosol topically administered in the surgical wound of hysterectomy patients improved analgesia during the first postoperative day with minimal risk of side effects.
为改善术后镇痛效果,局部麻醉药已在围手术期作为浸润麻醉或气雾剂应用于手术区域。此前一项研究表明,在腹部外小手术(疝修补术)中,局部应用利多卡因对伤口有良好的镇痛效果,而在小的下腹部剖腹手术中进行同样的治疗并未改善术后镇痛效果。本研究调查了利多卡因气雾剂局部伤口麻醉对下腹部大手术后疼痛的影响。
在一项双盲随机试验中,对30例行子宫切除术的患者的术后疼痛和镇痛需求进行了研究。患者被随机分为两组,一组接受500mg利多卡因气雾剂(100mg/ml;瑞典阿斯特拉公司的赛罗卡因气雾剂)单次伤口治疗(n = 15),另一组接受安慰剂气雾剂治疗(n = 15)。术后疼痛采用视觉模拟评分法(VAS)进行评估。监测术后阿片类镇痛药(丁丙诺啡)的需求情况。
与安慰剂气雾剂相比,利多卡因气雾剂在术后休息时(VAS)诱导出显著更好的镇痛效果(P < 0.001),且术后第1个24小时内丁丙诺啡的需求显著减少(P < 0.001)。术后第2天两组间疼痛评分(VAS)和丁丙诺啡需求的差异不显著。术后24小时活动时,接受利多卡因气雾剂治疗组的平均疼痛评分显著更低(P < 0.05)。利多卡因给药后4小时血浆利多卡因浓度远低于中毒水平,术后48小时仍可检测到血浆利多卡因。未报告与药物相关的副作用。
在子宫切除患者的手术伤口局部给予单剂量利多卡因气雾剂可在术后第1天改善镇痛效果,且副作用风险极小。